Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Kim

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Parkinsonism & Related Disorders|May 5, 2015
[(18)F] FP-CIT PET study in parkinsonian patients with leukoaraiosisM J Lee, S L Kim, H I Kim, et al.
HGG Advances|May 22, 2023
Genetic and clinical determinants of telomere lengthPatrick Allaire, Jing He, John Mayer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 24, 2021
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter ExperienceSeth A Wander, Hyo S Han, Mark L Zangardi, et al.
JCO Precision Oncology|May 4, 2023
A Gene Panel Associated With Abemaciclib Utility in <i>ESR1</i>-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor ProgressionJamie O Brett, Taronish D Dubash, Gabriela N Johnson, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Parkinsonism & Related Disorders|May 5, 2015
[(18)F] FP-CIT PET study in parkinsonian patients with leukoaraiosisM J Lee, S L Kim, H I Kim, et al.
HGG Advances|May 22, 2023
Genetic and clinical determinants of telomere lengthPatrick Allaire, Jing He, John Mayer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 24, 2021
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter ExperienceSeth A Wander, Hyo S Han, Mark L Zangardi, et al.
JCO Precision Oncology|May 4, 2023
A Gene Panel Associated With Abemaciclib Utility in <i>ESR1</i>-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor ProgressionJamie O Brett, Taronish D Dubash, Gabriela N Johnson, et al.
Pageof 3